{"id":"hyperpolarized-129-xenon","safety":{"commonSideEffects":[{"rate":null,"effect":"Minimal adverse events reported; generally well-tolerated"}]},"_chembl":{"chemblId":"CHEMBL4594411","moleculeType":"Small molecule","molecularWeight":"128.90"},"_dailymed":{"setId":"70e33fe3-c722-439b-b3db-c2a22f229c8a","title":"XENOVIEW (XENON XE 129 HYPERPOLARIZED) GAS [POLAREAN, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Xenon-129 is hyperpolarized (aligned nuclear spins) to increase its MRI signal sensitivity by several orders of magnitude, allowing real-time imaging of air distribution in the lungs and measurement of gas diffusion across the alveolar-capillary membrane. This enables functional assessment of pulmonary ventilation and perfusion without ionizing radiation, providing detailed maps of regional lung function.","oneSentence":"Hyperpolarized 129 xenon is inhaled as a contrast agent for magnetic resonance imaging (MRI) that enhances visualization of lung ventilation and gas exchange.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:31:11.060Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary ventilation and gas exchange imaging in patients with chronic obstructive pulmonary disease (COPD)"},{"name":"Assessment of lung function in cystic fibrosis"},{"name":"Evaluation of asthma and other obstructive airway diseases"}]},"trialDetails":[{"nctId":"NCT06856525","phase":"PHASE2, PHASE3","title":"Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology","status":"RECRUITING","sponsor":"Y. Michael Shim, MD","startDate":"2024-12-19","conditions":"Electronic Cigarette Related Lung Damage","enrollment":80},{"nctId":"NCT06104228","phase":"PHASE2","title":"129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-08-12","conditions":"Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)","enrollment":20},{"nctId":"NCT05241275","phase":"PHASE2","title":"Xenon MRI and Progressive ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2022-07-19","conditions":"Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis","enrollment":60},{"nctId":"NCT06351345","phase":"PHASE2","title":"129 Xenon Imaging in Patients Treated With Sotatercept","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-10-27","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":14},{"nctId":"NCT02272049","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-12","conditions":"Respiratory Disorders","enrollment":300},{"nctId":"NCT06012500","phase":"PHASE1, PHASE2","title":"Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-04-14","conditions":"ILD","enrollment":78},{"nctId":"NCT05041140","phase":"","title":"Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-08-14","conditions":"Pulmonary, Pneumonia, Hematopoietic System--Cancer","enrollment":25},{"nctId":"NCT04035629","phase":"PHASE1","title":"129Xe MRI in Pediatric Population With BPD","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2026-08-01","conditions":"Bronchopulmonary Dysplasia","enrollment":""},{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT04995562","phase":"PHASE4","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-05-06","conditions":"Lungs; Developmental Disorder","enrollment":12},{"nctId":"NCT04071769","phase":"PHASE2","title":"Genentech Xenon MRI Idiopathic Pulmonary Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-08-03","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":34},{"nctId":"NCT05914506","phase":"","title":"Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2023-10-05","conditions":"Progressive Fibrosing Interstitial Lung Disease","enrollment":30},{"nctId":"NCT07139899","phase":"","title":"Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-11-17","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT03603899","phase":"PHASE1, PHASE2","title":"Hp129 Xenon Imaging and BOS in Lung Transplantation","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-09-09","conditions":"Bronchiolitis Obliterans","enrollment":3},{"nctId":"NCT04941573","phase":"","title":"Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2021-01-19","conditions":"Lung Transplant Rejection","enrollment":45},{"nctId":"NCT02316379","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-02","conditions":"Respiratory Disorders","enrollment":100},{"nctId":"NCT04726618","phase":"","title":"Development of Hardware and Software for Pulmonary Magnetic Resonance Imaging Using Inhaled Tracer Gases","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2022-03-01","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT03733535","phase":"NA","title":"Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-03-01","conditions":"Asthma; Eosinophilic","enrollment":29},{"nctId":"NCT06985225","phase":"","title":"Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2025-06","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT06819969","phase":"","title":"The Canadian Lung Outcomes in Users of Vaping Devices Study","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-02","conditions":"Small Airways Diseases, Vaping, Vaping Related Disorder","enrollment":500},{"nctId":"NCT02748798","phase":"EARLY_PHASE1","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2020-11-10","conditions":"Lung Transplant, Lung Resection, Lung Cancer","enrollment":10},{"nctId":"NCT02723500","phase":"NA","title":"129 Xenon MRI in Chronic Lung Disease","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Lung Disease","enrollment":100},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT02151604","phase":"PHASE2","title":"Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2014-04-23","conditions":"Non-small Cell Lung Cancer","enrollment":22},{"nctId":"NCT02478255","phase":"PHASE2","title":"Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2016-03-21","conditions":"Radiation Injury","enrollment":25},{"nctId":"NCT04677426","phase":"PHASE2","title":"129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis","enrollment":""},{"nctId":"NCT02478268","phase":"PHASE1","title":"Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2015-05","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":64},{"nctId":"NCT04662658","phase":"PHASE1, PHASE2","title":"Hyperpolarized Xenon-129 MR Imaging of the Lung","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2020-11-05","conditions":"E-Cig Use","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["HP 129 Xe"],"phase":"marketed","status":"active","brandName":"Hyperpolarized 129 Xenon","genericName":"Hyperpolarized 129 Xenon","companyName":"Children's Hospital Medical Center, Cincinnati","companyId":"children-s-hospital-medical-center-cincinnati","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hyperpolarized 129 xenon is inhaled as a contrast agent for magnetic resonance imaging (MRI) that enhances visualization of lung ventilation and gas exchange. Used for Pulmonary ventilation and gas exchange imaging in patients with chronic obstructive pulmonary disease (COPD), Assessment of lung function in cystic fibrosis, Evaluation of asthma and other obstructive airway diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}